In the ever-evolving world of medical advancements, AMA Laboratories continues to push the boundaries of excellence with cutting-edge technology, improved efficiency, and enhanced patient care. AMA Laboratories’ key breakthroughs and initiatives continue to reshape the future of healthcare.
eClinicalWorks Update: Smarter, Faster, and More Customizable
A major highlight this month is the significant upgrade to the eClinicalWorks (eCW) system, a move designed to streamline operations for healthcare providers. This enhancement was made possible through the dedication of top-tier professionals, including Dr. Sacy, Dr. Manzer, and Kayla Manly, who developed custom templates and trained staff for smooth implementation. On the technical side, Adrian, Bobby, and Shana, played a pivotal role in collaborating with CGM and eCW technicians to improve result accuracy and ordering capabilities.
Now, providers can order critical tests such as eGFR, HCG, and A1C% directly from our laboratories, reducing wait times and improving patient outcomes. This upgrade exemplifies AMA Laboratories’ commitment to delivering precise and efficient healthcare solutions.
Breakthrough in Pharmacogenomics: PGX Testing Now Available
The expansion of Pharmacogenomic (PGX) testing across clinics in Missouri, Texas, and Georgia is another game-changer. This revolutionary assessment provides valuable insights into how patients metabolize medications, ensuring safer and more effective treatment plans for pain management, psychotropic medications, and cardiovascular treatments.
The PGX testing offers two key ordering pathways:
- PGX Detailed – Delivers an expansive exploration of genetic findings.
- PGX Summary – Offers the same essential insights in a more succinct format.
Both options capture the same crucial information, differing only in the depth of detail presented. This personalized approach to medication management and upgraded ordering pathway options allows providers to tailor treatments to individual patients, ensuring optimized care.
Commitment to Transparency: KPI Highlights
AMA Laboratories remains steadfast in its dedication to service quality and transparency. The latest KPI highlights demonstrate remarkable efficiency:
- Toxicology (Carthage): 71% Turnaround Time (TAT) within five days, 18% within seven days.
- PCR Testing (Texas): 73% TAT within three days, 91% within four days.
- AMMO MC Labs: 1804 requisitions containing 78444 individual assays, achieving a 98.1% TAT in under 48 hours.
This level of performance reflects AMA Laboratories’ unwavering pursuit of excellence and reliability in medical diagnostics.
Supporting Our Veterans: The Veterans Laboratory Services Program
A truly commendable initiative featured in this month’s update is the launch of the Veterans Laboratory Services Program, spearheaded by Mike McCallum of AMVA. This program is set to bring essential lab testing closer to home for U.S. veterans, many of whom live far from VA hospitals and clinics.
In collaboration with Veterans Evaluation Services (VES), a contractor for the U.S. Department of Veterans Affairs, AMA Laboratories is ensuring that veterans undergoing medical disability evaluations have easy access to lab services—without the burden of long-distance travel. This initiative underscores AMA Laboratories’ dedication to serving those who have served the nation.
The Future of Healthcare is Here
From EHR upgrades to groundbreaking PGX testing and unwavering effort to expand and deliver efficient and effective healthcare, AMA Laboratories is setting new standards in the industry. By prioritizing precision and patient-centric solutions, they continue to drive innovation and improve lives.
